Skip to content

Preparation Process of Sebum-Reducing Shampoo and Therapeutic Efficacy Observation for Seborrheic Alopecia (Damp-Heat Rising Pattern)

Preparation Process of Sebum-Reducing Shampoo and Therapeutic Efficacy Observation for Seborrheic Alopecia (Damp-Heat Rising Pattern)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000531
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-27
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seborrheic alopecia

Interventions

Treatment group:First, rinse the scalp and hair with warm water, squeeze out excess water, take 10ml of Yizhi Xiao shampoo, add 50ml of warm water to create a bath, massage the scalp, and allow the so
Control Group:First, rinse the scalp and hair with warm water, squeeze out excess water, then apply 2% ketoconazole shampoo, massage it into the scalp, and let it remain for 5 minutes before rinsing t

Sponsors

Beijing University of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria of this disease in both Traditional Chinese Medicine (TCM) and Western Medicine. (2) Age between 18 and 70 years old, regardless of gender. (3) Voluntarily participates and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1) With other diseases that may interfere with the results, such as: syphilitic alopecia, alopecia areata, senile alopecia, telogen effluvium, cicatricial alopecia, trichotillomania, lupus erythematosus-related alopecia, and other scalp skin diseases. 2) With severe systemic diseases, such as cardiovascular, liver, kidney diseases, or malignant tumors. 3) Known allergy to any components of the lipid-regulating shampoo, 2% ketoconazole shampoo, or other ingredients. 4) Use of topical or systemic corticosteroids within the past 2 weeks. 5) Women who are pregnant, breastfeeding, or planning to conceive. 6) Participation in other clinical drug trials within the past month. 7) History of major surgery or trauma within the past month. 8) Patients with mental illness, severe alcoholism, drug abuse, drug dependence, primary or secondary immunodeficiency, or other conditions deemed unsuitable for participation in the clinical trial by the investigator. 9) Use of topical antibiotics locally within 1 month prior to treatment or during the treatment period, or having received platelet-rich plasma (PRP), platelet-rich fibrin (PRF), concentrated growth factors (CGF), microneedling, laser therapy, roller needling, acupuncture point embedding, hair transplantation, or other treatments within the past month.

Design outcomes

Primary

MeasureTime frame
Clinical symptom scoring, including alopecia, sebum, pruritus, and scaling symptom scores.;

Secondary

MeasureTime frame
Hair Microscope Image Analysis Criteria;Dermatology Life Quality Index (DLQI);Patient Sleep Self-Assessment Scale;

Countries

China

Contacts

Public ContactSun Zhanxue, Yang Pingping

The Third Affiliated Hospital of Beijing University of Chinese Medicine

sunzhanxue@163.com13681412706

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026